LianBio Investing Cash Flow
LianBio (LIANY) reported Investing Cash Flow of $78.04 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2023-11-13
- LianBio net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $15.53M.
- LianBio net cash provided by (used in) investing activities for the quarter ending 2023-06-30 was $21.97M, a 34.70% decline year-over-year.
- LianBio net cash provided by (used in) investing activities for the quarter ending 2023-03-31 was $40.54M.
- LianBio net cash provided by (used in) investing activities for the quarter ending 2022-12-31 was $11.00M.
- LianBio net cash provided by (used in) investing activities for fiscal 2022 was -$69.20M.
- LianBio net cash provided by (used in) investing activities for fiscal 2021 was -$155.94M.
- LianBio net cash provided by (used in) investing activities for fiscal 2020 was -$886.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2023-09-30 | $15.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $37.50M derived: sum of 2 quarters · filed 2023-11-13 | $78.04M 10-Q · filed 2023-11-13 | $89.04M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $21.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $62.52M 10-Q · filed 2023-08-14 | $73.51M derived: sum of 3 quarters · filed 2023-08-14 | $35.00M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $40.54M 10-Q · filed 2023-05-11 | $51.54M derived: sum of 2 quarters · filed 2023-05-11 | $13.03M derived: sum of 3 quarters · filed 2023-11-13 | $46.68M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$27.52M derived: sum of 2 quarters · filed 2023-11-13 | $6.13M derived: sum of 3 quarters · filed 2023-11-13 | -$69.20M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$38.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$4.86M derived: sum of 2 quarters · filed 2023-11-13 | -$80.20M 10-Q · filed 2023-11-13 | -$235.97M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $33.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$41.69M 10-Q · filed 2023-08-14 | -$197.46M derived: sum of 3 quarters · filed 2023-08-14 | -$197.56M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$75.33M 10-Q · filed 2023-05-11 | -$231.11M derived: sum of 2 quarters · filed 2023-05-11 | -$231.20M derived: sum of 3 quarters · filed 2023-05-11 | -$231.24M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$155.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$155.87M derived: sum of 2 quarters · filed 2023-03-28 | -$155.91M derived: sum of 3 quarters · filed 2023-03-28 | -$155.94M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$130.00K derived: sum of 2 quarters · filed 2022-11-10 | -$159.00K 10-Q · filed 2022-11-10 | -$710.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$67.00K 10-Q · filed 2022-08-11 | -$618.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$29.00K 10-Q · filed 2022-05-12 | -$580.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$551.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | -$886.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$335.00K 10-Q/A · filed 2022-01-10 |